Provided by Tiger Trade Technology Pte. Ltd.

Harrow Health Inc

36.58
-0.9700-2.58%
Post-market: 36.580.00000.00%17:28 EDT
Volume:371.11K
Turnover:13.61M
Market Cap:1.37B
PE:-36.61
High:37.23
Open:37.23
Low:36.37
Close:37.55
52wk High:54.85
52wk Low:28.54
Shares:37.49M
Float Shares:28.93M
Volume Ratio:0.91
T/O Rate:1.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9993
EPS(LYR):-0.1400
ROE:-116.07%
ROA:-0.45%
PB:90.22
PE(LYR):-261.29

Loading ...

Stock Track | Harrow Health Plunges 7.99% After Hours on Q1 Earnings Miss and Widened Loss

Stock Track
·
May 12

Harrow Q1 revenue misses analyst estimates

Reuters
·
May 12

Harrow Q1 EPS $(0.74) Misses $(0.39) Estimate, Sales $44.203M Miss $52.420M Estimate

Benzinga Earnings
·
May 12

Harrow Inc Q1 Gross Margin 61%

THOMSON REUTERS
·
May 12

Harrow Inc Q1 EPS USD -0.74

THOMSON REUTERS
·
May 12

Harrow Announces First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 12

Earning Preview: Harrow Health Inc revenue is expected to decrease by 8.03% this quarter, and institutional views are bullish

Earnings Agent
·
May 04

Harrow updates financial calendar with upcoming quarterly results release and conference call

Reuters
·
Apr 27

Harrow announces annual shareholder meeting

Reuters
·
Apr 25

Harrow Price Target Maintained With a $63.00/Share by BTIG

Dow Jones
·
Apr 17

Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW) and BioCryst (BCRX)

TIPRANKS
·
Apr 16

Harrow announces issuance of J-Code for Iopidine 1%

TIPRANKS
·
Apr 16

Harrow Inc - Iopidine 1% Assigned Permanent J-Code J2374 by CMS Effective July 1, 2026

THOMSON REUTERS
·
Apr 16

Press Release: Harrow Announces the Issuance of J-Code for IOPIDINE(R) 1%

Dow Jones
·
Apr 16

Harrow selects LogiCare3PL as U.S. distribution partner for ophthalmic products

Reuters
·
Apr 14

Harrow Price Target Cut to $65.00/Share From $74.00 by B. Riley Securities

Dow Jones
·
Apr 08

Harrow price target lowered to $65 from $74 at B. Riley

TIPRANKS
·
Apr 07

Harrow Inc : B. Riley Cuts Target Price to $65 From $74

THOMSON REUTERS
·
Apr 07

B. Riley Lowers Price Target on Harrow to $65 From $74, Keeps Buy Rating

MT Newswires Live
·
Apr 07

How Investors May Respond To Harrow (HROW) Upsizing Its 2030 Unsecured Notes For Growth Flexibility

Simply Wall St.
·
Apr 01